MKSI vs TLRY · P/E 93, rev $2.33B vs rev $915.5M
MKS Instruments Inc (MKSI) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
MKS Instruments Inc (MKSI) is a scientific & technical instruments company listed on US.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported MKSI revenue for 2026-06-30 was $2.33B. Net income was $258.0M. MKSI currently screens at market cap $30.04B and trailing P/E 93.4.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
MKSI currently screens at market cap $30.04B and trailing P/E 93.4. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the MKSI and TLRY stock pages for the full models.
Not investment advice.